TABLE 1 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Mono Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Mono Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Combination Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Combination Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Alpha Blockers Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Alpha Blockers Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific 5- alpha Reductase Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific 5- alpha Reductase Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Phosphodiesterase-5 Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Phosphodiesterase-5 Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 21 China Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 22 China Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 23 China Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 24 China Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 25 China Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 26 China Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 27 Japan Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 28 Japan Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 29 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 30 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 31 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 32 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 33 India Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 34 India Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 35 India Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 36 India Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 37 India Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 38 India Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 39 South Korea Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 40 South Korea Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 41 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 42 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 43 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 44 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 45 Singapore Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 46 Singapore Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 47 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 48 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 49 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 50 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 51 Malaysia Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 52 Malaysia Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 53 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 54 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 55 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 56 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 57 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 58 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 59 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 60 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 61 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 62 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 63 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 64 key information – Astellas Pharma, Inc.
TABLE 65 Key Information – Eli Lilly and Company
TABLE 66 Key Information – Allergan PLC
TABLE 67 key Information – Merck Group
TABLE 68 Key Information – Boehringer Ingelheim International GmbH
TABLE 69 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 70 Key Information – Sanofi S.A.
TABLE 71 Key Information – Pfizer, Inc.
TABLE 72 Key Information – Abbott Laboratories
List of Figures
FIG 1 Methodology for the research
Unique Offerings 